What the label states, the lot delivers — net peptide mass, not gross powder weight, purity reported as measured rather than rounded up, and a Certificate of Analysis for every lot.
Net peptide mass, not powder weight; purity as measured, not rounded up; a COA per lot.
Net peptide + purity not rounded up. COA per lot.
FDA PCAC reviews 7 peptides for the 503A bulks list (BPC-157, KPV, TB-500, MOTs-C, Emideltide, Semax, Epitalon). Read our compounder's decision tree. Read our briefing →
FDA PCAC reviews 7 peptides for the 503A bulks list in July. Read →
FDA PCAC: 7 peptides under review. Read →
Long-acting GLP-1 Fc-fusion research reference (Trulicity analog)
Overview
Dulaglutide (brand name Trulicity) is a long-acting GLP-1 receptor agonist fusion protein developed by Eli Lilly. It was approved by the FDA in September 2014 for glycemic control in type 2 diabetes, and gained a second approval in February 2020 for reducing major adverse cardiovascular events in type 2 diabetes patients with established cardiovascular disease or multiple cardiovascular risk factors. Vialdyne releases Dulaglutide as a lyophilized peptide against a ≥95% (SEC/RP-HPLC) HPLC main-peak specification, supplied with a batch-specific Certificate of Analysis covering RP-HPLC purity, mass-spec identity, appearance, and water content. Lots are released only after the COA is on file.
Applications & buyer fit
Most buyers in this category are 503A and 503B compounding pharmacies fulfilling metabolic and weight-management protocols, plus research labs investigating GLP-1 / GIP / GCG receptor pharmacology. The procurement decision usually hinges on three things: documented purity at scale, a regulatory team that can respond on destination-market questions in writing, and the ability to supply consistent counter-ion form (acetate by default) across recurring orders.
Sourced for
Buyer fit
Documentation that ships
Procurement note: Supplied as a documented active in acetate counter-ion form by default; the buyer verifies current scheduling and compounding eligibility for the destination market.
Primary buyer fit: academic and contract research laboratories.
Specifications
Certificate of Analysis
Published released-batch COAs for Dulaglutide, every lot HPLC-verified. These are previews — request the full high-resolution certificate for any lot.
VerifiedRequest full COA →Dulaglutide
VD260428-DUL067 · 99.56%
VerifiedRequest full COA →Dulaglutide
VD260428-DUL066 · 99.66%
Regulatory note
Research-use-only reference material; not for human or veterinary use.
Selected literature
Frequently asked questions
Dulaglutide ships as white lyophilized powder with a batch-specific Certificate of Analysis reporting RP-HPLC purity (≥95% (SEC/RP-HPLC)), mass-spec identity, and appearance. Recommended storage: -20°C; reconstituted 2–8°C. Supplied strictly as a research reference material — not for human or veterinary use.
Related peptides
GLP-1 receptor agonist
GIP / GLP-1 dual receptor agonist
GLP-1 receptor agonist (long-acting)
